• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AFFY:US

0.1000 USD 0.00000.00%

As of 20:10:00 ET on 08/01/2014.

Snapshot for Affymax Inc (AFFY)

Open: 0.1000 Day's Range: 0.1000 - 0.1100 Volume: 180,996
Previous Close: 0.1000 52wk Range: 0.0930 - 2.0300 1-Yr Rtn: -93.67%

Stock Chart for AFFY

No chart data available.
  • AFFY:US 0.1000
  • 1D
  • 1M
  • 1Y
0.1000
Interactive AFFY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AFFY

Current P/E Ratio (ttm) 1.2526
Estimated P/E(12/2014) -
Relative P/E vs. SPX 0.0717
Earnings Per Share (USD) (ttm) 0.0798
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 3.75
Shares Outstanding (M) 37.49
30 Day Average Volume 640,413
Price/Book (mrq) -
Price/Sale (ttm) 89.2619
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AFFY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AFFY

Affymax Inc. is a clinical-stage biopharmaceutical company. The Company develops peptide-based drugs for the treatment of serious and life-threatening conditions such as kidney disease and cancer.

Richard M Brenner "Rich"Chief Executive OfficerJ Weston Rose "Wes"President
Mark G ThompsonChief Financial Officer
More Company Profile & Key Executives for AFFY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil